SCHEMBL9944019

SCHEMBL9944019

NC(=O)Oc1ccc(-n2cnnn2)nc1

nearest known ligand 0.57

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 7/20 0.57
POLB P06746 2/20 0.51
BLM P54132 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
KMT2A Q03164 4/20 0.47
MAPT P10636 1/20 0.45
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.40
ALDH1A1 P00352 1/20 0.40
PKM P14618 1/20 0.40
ATF4 P18848 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2729430 0.86 KCNJ1 (0.65) KCNJ1POLBBLMTDP1KMT2A
SCHEMBL21460046 0.76 MAPT (0.58) KCNJ1POLBBLMTDP1KMT2A
SCHEMBL14921306 0.74 KCNJ1 (0.74) KCNJ1LMNAALDH1A1
SCHEMBL20357770 0.73 KCNJ1 (0.56) KCNJ1POLBBLMTDP1
SCHEMBL16897509 0.73 KCNJ1 (1.00) KCNJ1TDP1KMT2ALMNAALDH1A1
SCHEMBL14919593 0.72 KCNJ1 (0.71) KCNJ1KMT2AMAPTLMNAALDH1A1
SCHEMBL28284732 0.72 UBE2T (0.53) POLBKMT2AMAPTLMNAALDH1A1
SCHEMBL29177328 0.72 UBE2T (0.49) POLBKMT2AMAPTLMNAALDH1A1
SCHEMBL1164007 0.72 KCNJ1 (0.58) KCNJ1POLBBLMTDP1MAPT
SCHEMBL14069481 0.72 KCNJ1 (0.58) KCNJ1MAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2790511-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL Merck Sharp & Dohme Corp. (US) 2014-10-22 EP disclosed
WO-2013090271-A1 INHIBITORS OF THE RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2013-06-20 WO disclosed
EP-2464228-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT Merck Sharp & Dohme Corp. (US) 2012-06-20 EP disclosed